Was wir denken

Erfahren Sie mehr über unsere neuesten Einblicke, Ideen und Perspektiven. Hier finden Sie einen Ausblick auf unserer aktuellen Erkenntnisse und Denkanstöße für verschiedene Industrien und Branchen.

Trending Topics

Automotive Study
2024 Global Telecommunications Study results
Global Pricing Study 2025
Tariffs, pricing, and power
Better Growth in Retail and SME Banking
Wie kommen Unternehmen durch eine mögliche Rezession?
Durch Revenue Growth Management neue Wachstumspotenziale erschließen
Better Growth
Deutschland
hospital
März 05, 2025 | Blog

Deutsche Krankenhausreform: Maßnahmen für Medtech-Unternehmen

Healthcare & Life Sciences Digital Health & Health IT
Deutschland
hospital
März 05, 2025 | Blog

Deutsche Krankenhausreform: Implikationen für Medtech-Unternehmen

Healthcare & Life Sciences Digital Health & Health IT
Deutschland
latest report by Simon-Kucher and the German Association of Research-Based Pharmaceutical Companies (vfa)
Jan. 06, 2025 | Perspective | Report

Die Bedeutung der Orphan Drug-Regelung im AMNOG für die Patientenversorgung

Healthcare & Life Sciences Pharma & Biotechnologie
Simon-Kucher blog: Challenges of scaling at-home diagnostics
Nov. 03, 2025 | Blog

Challenges of scaling at-home diagnostics

Healthcare & Life Sciences Diagnostics
SK Insights: CDMO pricing 2025: Better value communication for growth
Okt. 17, 2025 | Blog

CDMO pricing 2025: Better value communication for growth

Healthcare & Life Sciences Healthcare B2B Suppliers
Simon-Kucher Insights: From pandemic spike to permanent shift: The rise of at-home diagnostics 
Okt. 16, 2025 | Blog

The rise of at-home diagnostics

Healthcare & Life Sciences Diagnostics
launch excellence blog image
Okt. 13, 2025 | Blog

Closing the biotech launch gap

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher case study: Global portfolio pricing and launch strategy for innovative oncology sequencing tests
| Case Study

Global portfolio pricing and launch strategy for innovative oncology sequencing portfolio

Healthcare & Life Sciences Diagnostics
Simon-Kucher Blog: Minimal Residual Disease in solid tumors: The next big thing in oncology diagnostics
Sep 15, 2025 | Blog

MRD in solid tumors: The future of oncology diagnostics

Healthcare & Life Sciences Diagnostics
Simon-Kucher insights: How liquid biopsies are driving change in cancer care
Sep 10, 2025 | Blog

Liquid biopsies: Challenges and growth drivers

Healthcare & Life Sciences Diagnostics
Case study banner_Assessing market fit and guiding R&D decisions for a novel diagnostics solution
| Case Study

Assessing market fit and guiding R&D decisions for a novel diagnostics solution

Healthcare & Life Sciences Diagnostics
Simon-Kucher Blog: From chaos to control: How pharma companies can master global price management
Aug 29, 2025 | Blog

How pharma companies move from pricing chaos to control

Healthcare & Life Sciences Pharma & Biotechnology
emerging thumb
Aug 25, 2025 | Perspective | Whitepaper

The new model for equitable access in LMICs

Healthcare & Life Sciences Healthcare Providers
China
Image header: 2025 NRDL outlook: A fork in the road
Aug 19, 2025 | Blog

NRDL 2025 outlook

Healthcare & Life Sciences Pharma & Biotechnology
China
Blog_What the latest volume-based procurement changes in China mean for pharma
Juli 23, 2025 | Blog

VoBP shifts in China: What pharma needs to know

Healthcare & Life Sciences Pharma & Biotechnology
Blog_Patient retention in the digital age
Juli 15, 2025 | Blog

Patient retention in the digital age

Healthcare & Life Sciences Healthcare Providers
Language
Search